METTL3 and non-small cell lung carcinoma: METTL3 overexpression can directly induce non-small cell lung cancer (NSCLC) cisplatin (DDP) resistance by promoting YAP (Yes1-associated transcriptional regulator) translation with high mRNA methylation (83).